TrialESMO open2025

Streptozotocin plus 5-fluorouracil followed by everolimus or the reverse sequence in patients with advanced pancreatic neuroendocrine tumors (SEQTOR-GETNE phase III study): a randomized clinical trial.

J Capdevila et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.